PharmEasy in early funding talks with SoftBank at double its valuation
PharmEasy seeks to raise $100 million from SoftBank at a valuation of about $400 million
The PharmEasy-SoftBank funding talks come at a time when online pharmacies are grappling with a court ban on their operations
Mumbai: Japan’s SoftBank Group Corp. is in early talks to invest close to $100 million in online medicine startup PharmEasy, three people aware of the matter said. PharmEasy is seeking a valuation of about $400 million in the latest round of funding, more than double what it was valued in the previous fundraising, the people cited above said on condition of anonymity.